MediPharm Labs responds to false accusations made by Apollo Technology Capital Corporation

From GlobeNewswire: 2025-05-29 17:31:00

MediPharm Labs Corp. is addressing baseless allegations of malfeasance made by Apollo Technology Capital Corporation in an attempt to mislead shareholders. The company recently completed a clean audit with MNP LLP and is in compliance with all financial reporting standards. Legal proceedings have been initiated by MediPharm against Apollo to address material misstatements. Founded in 2015, MediPharm specializes in pharmaceutical-quality cannabis products and holds a GMP license. The company operates in compliance with all applicable laws. Shareholders seeking assistance in voting can contact Sodali & Co for support. For more information, visit www.medipharmlabsagm.com. Contact MediPharm Labs Investor Relations at +1 416.913.7425 or [email protected] for further inquiries.



Read more at GlobeNewswire: MediPharm Labs Responds to Fabricated Allegations from